Elimination of human papillomavirus 16-induced tumors by a mucosal rAd5 therapeutic vaccination in a pre-clinical study
M. R. Braun, J. D. Lindbloom, A. C. Moore, K. A. Hodgson, E. G. Dora, S. N. Tucker
This study shows that mucosal rAd5 vaccines targeting HPV16 E6 and E7 proteins reduce tumor volume and improve survival in a mouse model of HPV-induced cancer.
bioRxiv · Mar 11, 2024 · PreprintImmunology